Viewing StudyNCT05862272



Ignite Creation Date: 2024-05-06 @ 7:01 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05862272
Status: RECRUITING
Last Update Posted: 2024-03-15
First Post: 2023-05-08

Brief Title: A Phase 3B Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Women with Uterine Fibroids or Endometriosis
Sponsor: Sumitomo Pharma Switzerland GmbH
Organization: Sumitomo Pharma Switzerland GmbH

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-08-14
Start Date Type: ACTUAL
Primary Completion Date: 2029-07
Primary Completion Date Type: ESTIMATED
Completion Date: 2030-09
Completion Date Type: ESTIMATED
First Submit Date: 2023-05-08
First Submit QC Date: May 8 2023
Study First Post Date: 2023-05-17
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-24
Last Update Post Date: 2024-03-15
Last Update Post Date Type: ACTUAL